Patents by Inventor Iain Donaldson

Iain Donaldson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11147296
    Abstract: The present application relates to methods for producing beverages with low levels of acids, cations and/or sugars. The methods comprise the step of removing acidic ions through an AX-REED membrane stack and optionally removing cations through a CX-REED membrane stack. In certain embodiments, the AX-REED and the CX-REEF membrane stacks are operated in parallel. The methods may also comprise a step of converting sugar to organic acid, while simultaneously removing the generated organic acid through the AX-REED membrane stack. The sugar may for example be converted with the aid of enzymes and/or microorganisms.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: October 19, 2021
    Assignee: Carlsberg Breweries A/S
    Inventors: Iain Donaldson, Zoran Gojkovic, Pia Vaag
  • Publication number: 20200045999
    Abstract: The present application relates to methods for producing beverages with low levels of acids, cations and/or sugars. The methods comprise the step of removing acidic ions through an AX-REED membrane stack and optionally removing cations through a CX-REED membrane stack. In certain embodiments, the AX-REED and the CX-REEF membrane stacks are operated in parallel. The methods may also comprise a step of converting sugar to organic acid, while simultaneously removing the generated organic acid through the AX-REED membrane stack. The sugar may for example be converted with the aid of enzymes and/or microorganisms.
    Type: Application
    Filed: August 30, 2019
    Publication date: February 13, 2020
    Applicant: Carlsberg Breweries A/S
    Inventors: Iain Donaldson, Zoran Gojkovic, Pia Vaag
  • Patent number: 10440977
    Abstract: The present application relates to methods for producing beverages with low levels of acids, cations and/or sugars. The methods comprise the step of removing acidic ions through an AX-REED membrane stack and optionally removing cations through a CX-REED membrane stack. In certain embodiments, the AX-REED and the CX-REEF membrane stacks are operated in parallel. The methods may also comprise a step of converting sugar to organic acid, while simultaneously removing the generated organic acid through the AX-REED membrane stack. The sugar may for example be converted with the aid of enzymes and/or microorganisms.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: October 15, 2019
    Assignee: CARLSBERG BREWERIES A/S
    Inventors: Iain Donaldson, Zoran Gojkovic, Pia Vaag
  • Publication number: 20150189907
    Abstract: The present application relates to methods for producing beverages with low levels of acids, cations and/or sugars. The methods comprise the step of removing acidic ions through an AX-REED membrane stack and optionally removing cations through a CX-REED membrane stack. In certain embodiments, the AX-REED and the CX-REEF membrane stacks are operated in parallel. The methods may also comprise a step of converting sugar to organic acid, while simultaneously removing the generated organic acid through the AX-REED membrane stack. The sugar may for example be converted with the aid of enzymes and/or microorganisms.
    Type: Application
    Filed: June 28, 2013
    Publication date: July 9, 2015
    Applicant: Carlsberg Breweries A/S
    Inventors: Iain Donaldson, Zoran Gojkovic, Pia Vaag
  • Patent number: 6444878
    Abstract: A selection method for selecting from a population of plant cells one or more genetically transformed plant cells is described. In the method, the population of plant cells includes selectable genetically transformed plant cells and possible non-transformed plant cells. Each of the selectable genetically transformed plant cells comprises a first expressible nucleotide sequence and optionally a second expressible nucleotide sequence. In the method, a component or a metabolic derivative thereof when present in a low concentration in a medium is a nutrient for both the selectable genetically transformed plant cells and the non-transformed plant cells. In the method, the component or the metabolic derivative thereof when present in a high concentration in a medium is toxic to the non-transformed plant cells.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: September 3, 2002
    Assignee: Danisco A/S
    Inventors: Iain A. Donaldson, Kirsten Bojsen, Kirsten Jorgensen, Morten Jorsboe
  • Patent number: 5994629
    Abstract: A method of selecting genetically transformed cells from a population of cells comprising introducing a desired nucleotide sequence and a co-introduced nucleotide sequence into the genome of a cell whereby the desired nucleotide sequence or the co-introduced nucletoide sequence induces a positive effect by giving the transformed cells a competitive advantage when the population of cells are supplied with an inactive compound thereby allowing the transformed cells to be identified and selected from the non-transformed cells by means defined as positive selection; as well as cells transformed according to the method and plants derived therefrom. The invention further relates to novel glucuronide compounds including cytokinin glucuronide compounds for use in the method.
    Type: Grant
    Filed: September 13, 1995
    Date of Patent: November 30, 1999
    Assignee: Novartis AG
    Inventors: Kirsten Bojsen, Iain Donaldson, Anna Haldrup, Morten Joersboe, Jette D. Kreiberg, John Nielsen, Finn T. Okkels, Steen G. Petersen, Robert J. Whenham
  • Patent number: 5767378
    Abstract: The present invention provides a method for identifying or selecting from a population of eukaryotic cells cultivated on or in a medium containing at least one compound, cells which have a metabolic advantage as a result of having being transformed, wherein:i) the cells are transformed with a nucleotide sequence or a co-introduced nucleotide sequence one of which comprises a region which: (a) encodes a protein which is involved in the metabolism of the compound, and/or (b) regulates the activity of the protein; andii) the compound is mannose or xylose or a derivative or a precursor of these, or a substrate of the protein, or is capable of being metabolized by the transformed cells into such a substrate, with the proviso that the compound is not mannose when the protein is mannose 6 phosphate isomerase.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: June 16, 1998
    Assignee: Novartis AG
    Inventors: Kirsten Bojsen, Iain Donaldson, Anna Haldrup, Morten Joersboe, Jette Dina Kreiberg, John Nielsen, Finn Thyge Okkels, Steen Guldager Petersen